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ABSTRACT  
 
Introduction: This study is aimed to examine the predominant inflammatory cells in nasal polyps (NP) in the 
local community and its correlation to the clinical presentations. Materials and Methods: The study was 
done retrospectively looking at patients who had undergone functional endoscopic sinus surgery (FESS) in 
Hospital Universiti Sains Malaysia (HUSM), Kelantan, Malaysia with a histopathological diagnosis of nasal 
polyposis (NP), between the years 2004 to 2008. Sixty two patients between the ages of 18 years to 60 years 
old were selected and data relevant to the study were collected from the patient’s folders using a specially 
created form prepared for the study. The NP histopathology report from each patient underwent FESS were 
analysed and the patients were divided into eosinophilic and non eosinophilic dominant group. Clinical 
presentations from each patient were also gathered and analysed according to the NP group. Results: In 
HUSM, there were a higher number of eosinophilic types NP as compared to the neutrophilic type NP which 
is contrary to other study conducted on Asian populations. The clinical symptom correlations between either 
eosinophilic or non-eosinophilic type of NP have not shown any significant associations. Conclusion: The 
study showed that the incidence of histological subtypes of nasal polyp in HUSM is almost the same as that 
found in other parts of the world (Europe and North America) which will reduce the possibility of racial or 
geographical influence on the pathogenesis of the nasal polyp. Clinical symptoms and presentation alone are 
not enough to differentiate the type of the nasal polyp without the histological study. 
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INTRODUCTION  
 
The prevalence of nasal polyps (NP) in the adult 
European and US population is about 2.7% and 1-4%, 
respectively1,2. NP shows gender predominance with 
male to female ratio of 2:13. Pearlman et.al 
observed that NP most commonly presented in 
patients’ age between 40–60 years old while patients 
over 80 years of age were unlikely to have NP. They 
also noted that the mean age at diagnosis was 51 
years old in males and 49 years old in females 4.   
 
Between 19% and 36% of patients with chronic 
rhinosinusitis were reported to have NP 2. Symptoms 
of NP include bilateral nasal blockage, nasal 
discharge and facial pain or pressure. In addition, it 
also causes loss of smell, headache and reduced 
general well-being5. The relationship between 
sinusitis and the nasal polyps is critical whereby the 
inflammation is believed to be the trigger to the 
polypoidal formation and part of the spectrum for 
chronic rhinosinusitis 3. 
 
Histologically, NP is covered predominantly by 
respiratory pseudostratified epithelium with ciliated 
and goblet cells. NP consists of loose connective 
tissue, oedematous stroma and inflammatory cells. 
The oedematous stroma contains inflammatory     
cells which are mainly eosinophils, neutrophils, 
mast cells, plasma cells, lymphocytes, monocytes, 
fibroblasts and macrophages6. The predominant 
inflammatory cells found in NP are eosinophilia 
consisting around 80-90% 7, 8.  
 
In a Caucasian population, NP has been shown to 
have a strong eosinophilic component 5 whereas NP 
in Asian population shows a neutrophilic pattern9. 
However, the clinical presentation of NP remains 
similar between Asians and Caucasians.  
 
This study is aimed to examine the predominant 
inflammatory cells in nasal polyps in the local 
community and its correlation to the clinical 
presentations. 
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MATERIALS AND METHODS  
 
The study was done retrospectively looking at 
patients who had undergone functional endoscopic 
sinus surgery (FESS) in Hospital Universiti Sains 
Malaysia (HUSM), Kubang Kerian, Malaysia with a 
histopathological diagnosis of nasal polyposis, 
between the years 2004 to 2008. Ethical clearance 
for this study was obtained from the Human Ethics 
Committee of Universiti Sains Malaysia. Sixty two 
patients between the ages of 18 years to 60 years 
old were selected and data relevant to the study 
were collected from the patient’s folders using a 
specially created form prepared for this purpose. All 
the subjects are Malay, the dominant ethnic group 
in Kelantan. The details gathered from the form 
include demographic data, the initial clinical 
symptoms and signs, histology of the NP, 
radiological findings and treatment modalities. 
Patients with concurrent nasal diseases other than 
nasal polyps were excluded from the study. 
 
The data were analysed using the Statistical 
Package for the Social Sciences (SPSS) version 18.  
Descriptive analyses were used to describe the 
means, standard deviations, frequency and 
percentage. To compare the clinical symptoms 
exact Fisher test and STATA software was used. The 
level of significance was set at 0.05. If the p-value is 
less than 0.05 it will be considered statistically 
significant.   
  
RESULTS  
 
Nasal Polyps (NP) 
The NP were graded clinically into three grades 
depending on its relation to the middle turbinate 
10. About half of the patients had grade 2 NP 
(n=30); NP which extends inferiorly from the middle 
meatus beyond the inferior margin of the middle 
turbinate. The other half of the patients had grade 
1 NP (n=15); polyps seen confined within the middle 
meatus and grade 3 NP (n=17) where the polyps 
extended beyond the middle meatus and touching 
the nasal floor (Figure 1). Fifty one patients had 
bilateral NP and only 11 patients had unilateral 
diseases which represent around 18% of the study 
sample.  The gender ratio was 36 females to 26 
males. The age range was from 15 to 76 years old 
with the mean was 45.1 years. 
 
 
 
 
 
NP and inflammatory cells 
Based on the histological findings from the 
histopathology report, the patients were then 
divided into two main groups, the eosinophilic and 
the non eosinophilic group. Fifty four (87%) patients 
had eosinophilic type polyps (Figure 2). The 
histopathology report in HUSM routinely did not 
state the type and amount of the non eosinophilic 
inflammatory cells.  It measures only the dominant 
percentage of either eosinophilic or non eosinophilic 
group. 
Figure 1: Number of patients vs. grade of nasal polyp 
Figure 2: The subtype of nasal polyposis  
Table I: The association between NP symptoms and the 
type of NP 
NP and symptoms 
Symptoms documented from the patients include 
nasal blockage, reduction in smell and rhinorrhea. 
Both eosinophilic (92.6%) and non eosinophilic 
(87.5%) type NP group showed almost a similar 
percentage of nasal blockage presentation (Table I). 
A total of 44 patients from both groups have 
reduced smell. There were no significant 
association between nasal polyp type and symptoms 
of reduction in smell and rhinorrhea (Table I). 
  
Polyp type 
Fisher’s 
exact 
test 
Eosino-
philic 
Non           
eosino-
philic 
Nasal  
blockage 
Present 
50 
(92.6%) 
4 (7.4%) 
0.511 
Absent 7 (87.5%) 
1 
(12.5%) 
Smell     
abnormality 
Present 
39 
(72.3%) 
15 
(27.7%) 
0.098 
Absent 5 (62.5%) 
3 
(37.5%) 
Rhinorhea 
Present 
45(83%) 9(16.7%) 
0.623 
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DISCUSSION 
 
Retrospectively NP patients in HUSM have a higher 
number of eosinophilic types NP as compared to the 
non eosinophilic type NP. It correlates well with 
studies among the western populations where 
eosinophilic were the dominant inflammatory cells. 
The eastern Asian populations on the other hand, 
have a dominant non eosinophilic type NP11. In 
HUSM, the histopathological report only gave the 
total percentage of inflammatory cell types either 
eosinophilic or non eosinophilic type. The report did 
not calculate and analyze each inflammatory cell in 
the non eosinophilic group.  
 
Zhang et al. attempted to further characterize the 
variations seen in Asian polyps. Polyp tissue samples 
from 27 Chinese patients from the Guangdong 
province of China were harvested. The samples were 
compared to a group of matched Caucasian Belgian 
patients, where Chinese polyps had a significantly 
lower incidence of eosinophils12. Studies in          
China and Japan showed that the predominant 
inflammatory cells in NP were the neutrophilic         
type11,13. 
 
In this study, the clinical symptom correlations 
between either eosinophilic or non eosinophilic type 
of nasal polyps have not shown any significant 
associations. None of the symptoms presented were 
able to differentiate between both types of NP. 
Zhang et al. also reported in their study that there 
were similarity in symptom presentation between 
the Chinese and the Belgian group of patients12. 
 
The youngest patient in our study was 15 years old 
and the oldest was 76 years old. The peak of the 
presentation was in the 4th and 5th decade and 
noted to decline on both extremities of age. These 
findings correlate with reported literature 14. The 
number of male (n=26) and female (n=36) patients in 
this study resembles an earlier study by Settipan et 
al. In their review of 211 NP patients, there was an 
almost equal distribution of males and females, 50.2 
and 49.8%, respectively 15 but results from the more 
recent literature suggested that higher male to 
female ratio. The male: female ratio of patients 
with NP was 2.9 in ages 40–50 and maximal at 6.0 for 
patients between 80–89 years of age 2, 4. 
 
In contrary to other studies on Asian population, this 
study showed a higher eosinophilic type NP as 
compared to the neutrophilic type NP. We also 
concluded that the type of NP whether it is 
eosinophilic or non eosinophilic type, have no 
significant association with the clinical presentation 
of NP patients in HUSM. A similar study conducted in 
Japan has also concluded the same result and 
suggested the use of other parameters such as CT 
Scans, blood test and the presence of co-morbid 
allergic diseases which yield more accurate findings 
16. In most previous studies, patient with dominant 
eosinophilic type NP have a poor prognosis and more 
recurrence rates as compared to the non 
eosinophilic type NP17, therefore other parameters 
suggested by Sakuma et al. should be studied in 
order to predict the type of NP and hence 
determining the success of the subsequent 
management of NP. 
 
CONCLUSION 
 
HUSM has a higher number of eosinophilic types           
of NP similar to prevalence studies in the         
western population. The types of NP whether it          
is eosinophilic or non eosinophilic type, have no 
significant association with the patients’ clinical 
presentation of NP in HUSM. The symptoms and 
clinical presentation is not dependent on the 
histology of the nasal polyp. 
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